Lung-restricted antibodies lead to lung allograft rejection

Project: Research project

Project Details

Description

Lung allografts have the worst survival of all solid organs with >50% graft loss at 5 years. Primary graft dysfunction (PGD), characterized by pulmonary edema and hypoxemic respiratory failure, occurs within the first 24 to 72 hours of lung transplantation in over 50% of lung recipients and remains the predominant cause of early post-transplant mortality as well as chronic rejection. As such, amelioration of PGD has the potential to dramatically improve both the short- and long-term outcomes following lung transplantation.
StatusFinished
Effective start/end date7/1/1710/31/18

Funding

  • International Society for Heart & Lung Transplantation (AGREEMENT 5/4/17)

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.